Product Images Flarex

This is a pharmaceutical product for topical ophthalmic use only. It contains Activ fluorometholone acetate 0.1 and benzalkonium chloride 0.01%. The product should be stored upright between 2 to 25°C and protected from freezing. The recommended dosage is one to two drops into the conjunctival sacs four times daily, and it can be increased to two drops every two hours within the first 24 to 48 hours. If there is no improvement after two weeks, a physician should be consulted. Discontinuing the therapy prematurely should be avoided. The product is manufactured by Eyevance Pharmaceuticals, LLC in Italy, and it's not available for sale as it's a sample.*

This is a prescription-only medication called Fluorometholone acetate, which is sterile and intended for topical use in the eyes. It contains 0.1% (1 mg) of the active ingredient Fluorometholone acetate and benzalkonium chloride 0.01% as a preservative. Before use, shake the bottle well. Recommended dosage is one to two drops in each eye's conjunctival sac, four times per day, which can be increased to two drops every two hours safely over the first 24 to 48 hours if required. If there is no improvement after 10 weeks of use, consult a physician. This medication should not be discontinued prematurely. Store this medication upright between 2°C -25°C (36°F -77°F) and protect it from freezing.*

Flarex (fluorometholone acetate ophthalmic suspension) 0.1% is a prescription medication used to treat inflammation of the eye. It should be stored upright between 2°C and 25°C, protected from freezing. Each mL contains fluorometholone acetate 0.1% as an active ingredient, with benzalkonium chloride 0.01% as a preservative, and other inactive ingredients. The recommended dosage is one to two drops in the conjunctival sac(s) four times daily, with a possible increase in dosage within the first 24-48 hours. Premature discontinuation of treatment should be avoided, and any improvement after two weeks should be discussed with a physician. Flarex is produced by Eyevance Pharmaceuticals in Italy.*